| The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study M Imwong, K Suwannasin, C Kunasol, K Sutawong, M Mayxay, H Rekol, ... The Lancet Infectious Diseases 17 (5), 491-497, 2017 | 495 | 2017 |
| Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological … RW van der Pluijm, M Imwong, NH Chau, NT Hoa, NT Thuy-Nhien, ... The Lancet infectious diseases 19 (9), 952-961, 2019 | 317 | 2019 |
| Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study WL Hamilton, R Amato, RW van der Pluijm, CG Jacob, HH Quang, ... The Lancet Infectious Diseases 19 (9), 943-951, 2019 | 278 | 2019 |
| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 224 | 2020 |
| Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study M Imwong, M Dhorda, KM Tun, AM Thu, AP Phyo, S Proux, K Suwannasin, ... The Lancet Infectious Diseases 20 (12), 1470-1480, 2020 | 131 | 2020 |
| The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial L Von Seidlein, TJ Peto, J Landier, TN Nguyen, R Tripura, ... PLoS medicine 16 (2), e1002745, 2019 | 129 | 2019 |
| Triple artemisinin-based combination therapies for malaria–a new paradigm? RW van der Pluijm, C Amaratunga, M Dhorda, AM Dondorp Trends in parasitology 37 (1), 15-24, 2021 | 111 | 2021 |
| Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination CG Jacob, N Thuy-Nhien, M Mayxay, RJ Maude, HH Quang, ... Elife 10, e62997, 2021 | 71 | 2021 |
| Investigating the efficacy of triple artemisinin-based combination therapies for treating Plasmodium falciparum malaria patients using mathematical modeling S Dini, S Zaloumis, P Cao, RN Price, FJI Fowkes, RW Van Der Pluijm, ... Antimicrobial agents and chemotherapy 62 (11), 10.1128/aac. 01068-18, 2018 | 61 | 2018 |
| Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response L Zhu, RW van der Pluijm, M Kucharski, S Nayak, J Tripathi, NJ White, ... Communications Biology 5 (1), 274, 2022 | 52 | 2022 |
| The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background L Zhu, J Tripathi, FM Rocamora, O Miotto, R van der Pluijm, TS Voss, ... Nature communications 9 (1), 5158, 2018 | 50 | 2018 |
| Safety, pharmacokinetics, and mosquito‐lethal effects of ivermectin in combination with dihydroartemisinin‐piperaquine and primaquine in healthy adult Thai subjects KC Kobylinski, P Jittamala, B Hanboonkunupakarn, S Pukrittayakamee, ... Clinical Pharmacology & Therapeutics 107 (5), 1221-1230, 2020 | 41 | 2020 |
| Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label … TJ Peto, R Tripura, JJ Callery, D Lek, HDT Nghia, C Nguon, NTH Thuong, ... The Lancet Infectious Diseases 22 (6), 867-878, 2022 | 39 | 2022 |
| Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples MMA Hamid, MH Abdelraheem, DO Acheampong, A Ahouidi, M Ali, ... Wellcome open research 8, 2023 | 33 | 2023 |
| Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations P Tindana, F de Haan, C Amaratunga, M Dhorda, RW van der Pluijm, ... Malaria Journal 20, 1-7, 2021 | 30 | 2021 |
| The effect of iron loading and iron chelation on the innate immune response and subclinical organ injury during human endotoxemia: a randomized trial LT van Eijk, S Heemskerk, RW van der Pluijm, SM van Wijk, WHM Peters, ... haematologica 99 (3), 579, 2014 | 30 | 2014 |
| Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion M Imwong, K Suwannasin, S Srisutham, R Vongpromek, C Promnarate, ... Antimicrobial agents and chemotherapy 65 (12), 10.1128/aac. 01121-21, 2021 | 28 | 2021 |
| A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples M Kucharski, J Tripathi, S Nayak, L Zhu, G Wirjanata, RW Van Der Pluijm, ... Malaria Journal 19, 1-16, 2020 | 22 | 2020 |
| Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children … M Hamaluba, RW van der Pluijm, J Weya, P Njuguna, M Ngama, ... The Lancet Infectious Diseases 21 (10), 1395-1406, 2021 | 21 | 2021 |
| Triple artemisinin-based combination therapies for malaria: proceed with caution–Authors' reply RW van der Pluijm, AP Phyo, D Lek, NJ White, AM Dondorp The Lancet 396 (10267), 1976-1977, 2020 | 14 | 2020 |
